The Therascreen EGFR Mutation Test Kit was able to detect the presence of EGFR mutations when mutant DNA, relative to wild-type DNA, represented 1% of the total DNA in half of the tumours tested positive by the kit. The gene discussed is EGFR; the disease is neoplasm.